Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strontium ranelate versus placebo for alveolar bone quality before dental implantation in osteoporotic patients
2011-002370-23Phase 2Terminated
- Sponsor
- Servier
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoporosis and fragility fracture comparing Strontium ranelate with Placebo (2 arms). Primary endpoint: Alveolar bone quality and bone turnover. Started Dec 2011; status: terminated.
02
Drugs
strontium ranelate
03
Conditions
osteoporosisfragility fracture
Beyond the preview
Go deeper on 2011-002370-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002370-23.